Cost-utility analysis of newborn hepatitis B immunization in Beijing

References

• World Health Organization. (2017). Global hepatitis report 2017. World Health Organization.
   Google Scholar
• World Health Organization. Hepatitis B［EB/OL］. 2019 July 18. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
   Google Scholar
• World Health Organization. Hepatitis B［EB/OL］.2015 May 15. http://www.wpro.who.int/china/topics/hepatitis/qa_20150515/en/
   Google Scholar
• Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, Forouzanfour MH, Assadi R, Bhala N, Cowie B. The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of disease study 2013. Lancet. 2016;388(10049):1081–88. doi:10.1016/S0140-6736(16)30579-7.
   PubMed Web of Science ®Google Scholar
• Xiao-Jin S, Fu-Zhen W, Hui Z. Hbsag screening among pregnant women and neonatal immunization in six provinces of china,2014. Chinese Journal of Vaccines and Immunization; 2016.
   Google Scholar
• Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373(9663):582–92. doi:10.1016/S0140-6736(09)60207-5.
   PubMed Web of Science ®Google Scholar
• Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Sjalfoellah Noer HM, Leung N, Lesmana L, Phiet P. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol. 2000;15(12):1356–61. doi:10.1046/j.1440-1746.2000.0150121356.x.
   PubMed Web of Science ®Google Scholar
• World Health Organization, W. H.. 2015. Guidelines for the prevention, care and treatment of persons with chronic hepatitis b infection. World Health Organization.
   Google Scholar
• Monitoring and evaluation for viral hepatitis B and C: recommended indicators and framework. Geneva: World Health Organization; 2016. accessed May 2017. Available at http://apps.who.int/iris/bitstream/10665/204790/1/9789241510288_eng.pdf?ua=1
   Google Scholar
• Global Health Sector Strategy on viral hepatitis 2016–2021, towards ending viral hepatitis. Geneva: World Health Organization; 2016. [accessed April 2016]. http://apps.who.int/iris/bitstream/10665/246177/1/WHO-HIV-2016.06-eng.pdf
   Google Scholar
• World Health Organization. Hepatitis B vaccines: WHO position paper, July 2017–recommendations. Vaccine. 2019;37(2):223–25. doi:10.1016/j.vaccine.2017.07.046.
   PubMed Web of Science ®Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y. Evaluation of the impact of hepatitis B vaccination among children born during 1992–2005 in China. J Infect Dis. 2009;200(1):39–47. doi:10.1086/599332.
   PubMed Web of Science ®Google Scholar
• Cui FQ, Gong XH, Chen YS. Evaluation on impact of hepatitis B vaccine integrated into routine immunization in the areas of Ministry of Health/Global Alliance for Vaccine and Immunization (GAVI) Cooperation Project PR China. Zhong Guo Yi Miao He Mian Yi. 2009;15:289–93.
   PubMedGoogle Scholar
• Liao XY, Zhou ZZ, Wei FB, Qin HN, Ling Y, Li RC, Zhuang H, Nong Y, Sun K-X, Li J. Seroprevalence of hepatitis B and immune response to hepatitis B vaccination in Chinese college students mainly from the rural areas of western China and born before HBV vaccination integrated into expanded program of immunization. Hum Vaccin Immunother. 2014;10(1):224–31. doi:10.4161/hv.26311.
   PubMed Web of Science ®Google Scholar
• Gao P, Wang H, Chen WX, Sun YN, Wu J, Pang XH, He X, Wu J. A sero-epidemiological study of hepatitis b among general population in beijing. Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi. 2016;37(5):658–62. doi:10.3760/cma.j..0254-6450.2016.05.014.
   PubMedGoogle Scholar
• Ji-ye FU, Qi DING, Wei ZHANG, Ju-guang WANG, Min LIU. Efficacy of 10 μg recombinant hepatitis b vaccine in 128 infants 5 years after primary vaccination series in haidian district of beijing. Occup Health. 2017;33(3):366–69. doi:10.13329/j.cnki.zyyjk.2017.0107.
   Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y. Epidemiological serosurvey of hepatitis B in China—declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27(47):6550–57. doi:10.1016/j.vaccine.2009.08.048.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang W, Han LL, Lin CY, Ma LX, Xing Y-L, Gao P, Gong X-H, Liu L-R, Huang F. [a sero-epidemiologiecal study on hepatitis b among general population in beijing]. Zhonghua Liu Xing Bing Xue Za Zhi. 2007;28:555–57.
   PubMedGoogle Scholar
• Hung HF, Chen THH. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence. Vaccine. 2009;27(48):6770–76. doi:10.1016/j.vaccine.2009.08.082.
   PubMed Web of Science ®Google Scholar
• Kim SY, Salomon JA, Goldie SJ. Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves. Bull World Health Organ. 2007;85(11):833–42. doi:10.2471/BLT.06.038893.
   PubMed Web of Science ®Google Scholar
• Boccalini S, Taddei C, Ceccherini V, Bechini A, Levi M, Bartolozzi D, Bonanni P. Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an a posteriori evaluation and forecast of future benefits. Hum Vaccin Immunother. 2013;9(5):1119–28. doi:10.4161/hv.23827.
   PubMed Web of Science ®Google Scholar
• Lu SQ, McGhee SM, Xie X, Cheng J, Fielding R. Economic evaluation of universal newborn hepatitis B vaccination in China. Vaccine. 2013;31(14):1864–69. doi:10.1016/j.vaccine.2013.01.020.
   PubMed Web of Science ®Google Scholar
• Yin J, Ji Z, Liang P, Wu Q, Cui F, Wang F, Liang X, Zhuang G. The doses of 10 μg should replace the doses of 5 μg in newborn hepatitis B vaccination in China: A cost-effectiveness analysis. Vaccine. 2015;33(31):3731–38. doi:10.1016/j.vaccine.2015.05.082.
   PubMed Web of Science ®Google Scholar
• Beijing Municipal Bureau of Statistic NBS Survey Office in Beijing. Beijing statistical yearbook. [EB/OL]. [accessed 2019 July 16]. http://nj.tjj.beijing.gov.cn/nj/main/2017-tjnj/zk/indexeh.htm
   Google Scholar
• Beijing Municipal Health Commission Information Center. 1979-2018 average life expectancy of Beijing population [EB/OL]. [accessed 2019 April 23]. http://www.phic.org.cn/tjsj/wssjzy/jkzb/201304/t20130425_255009.html
   Google Scholar
• Lu Y, Liang XF, Wang FZ, Yan L, Li RC, Li YP, et al. Hepatitis b vaccine alone may be enough for preventing hepatitis b virus transmission in neonates of hbsag (+)/hbeag (?) mothers. Vaccine 2016; S0264410X16311239.
   Web of Science ®Google Scholar
• Fu-Zhen W, Xiao-Hong G, Li-Rong L. Analysis on infection of hepatitis b virus among pregnant women in beijing. Chinese Journal of Vaccines & Immunization; 2007.
   Google Scholar
• Lei Z, Xi-en G, Caroline T, et al. Effects of hepatitis b immunization on prevention of mother-to-infant transmission of hepatitis b virus and on the immune response of infants towards hepatitis b vaccine. Vaccine. 2014.
   Web of Science ®Google Scholar
• Wang F, Zhang G, Zheng H, Miao N, Shen L, Wang F, Dong P, Du F, Chen C, Zhang X, et al. Post-vaccination serologic testing of infants born to hepatitis b surface antigen positive mothers in 4 provinces of china. Vaccine. 2017;35(33):4229–35. doi:10.1016/j.vaccine.2017.06.019.
   PubMed Web of Science ®Google Scholar
• Shu-ying FENG. Observation on immune effect of hepatitis b vaccine in infants born to hbsag positive mothers. Journal of Shanxi Medical University; 2011.
   Google Scholar
• Zeng Y, Luo M, Lin J, He H, Deng X, Xie S, Fang Y. Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobulin treatment: a case study in Zhejiang Province, East China. Hum Vaccin Immunother. 2019;16(4):955–64. doi:10.1080/21645515.2019.1688031
   PubMed Web of Science ®Google Scholar
• Xiao M, Wang H, Zhang W, Pang XH, Qiu Q, Wang YH. Cost-effectiveness analysis of hepatitis B vaccination strategy for high risk adults in Beijing. Chin J Dis Control Prev. 2015;19:730–34.
   Google Scholar
• Yang PC. Development of markov models for hepatitisB vaccination or treatment and cost-effectiveness analysis of pro-phylactic entecavir use for population based-on community in China. Guangdong Pharmaceutical University; 2016.
   Google Scholar
• Jing-Jing L. Economic evaluation of hepatitis B immunization strategy among newborns in Shandong. Shandong University; 2013.
   Google Scholar
• Ni YH. Natural history of hepatitis B virus infection: pediatric perspective. J Gastroenterol. 2011;46(1):1–8. doi:10.1007/s00535-010-0304-7.
   PubMed Web of Science ®Google Scholar
• Tilson L, Thornton L, O’Flanagan D, Johnson H, Barry M. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation. Eur J Public Health. 2007;18(3):275–82. doi:10.1093/eurpub/ckm123.
   PubMed Web of Science ®Google Scholar
• Chu CM, Liaw YF, Yang CY, Sheen IS. Diagnosis of acute type B hepatitis by a solid phase u‐antibody capture radioimmunoassay for IgM class antibody to hepatitis B core antigen: a diagnostic proposal based on a prospective study. Liver. 1987;7(3):182–87. doi:10.1111/j.1600-0676.1987.tb00340.x.
   PubMedGoogle Scholar
• Liu J, Yang H, Lee M, Lu S, Jen C, Wang L, You S, Iloeje UH, Chen C. Incidence and determinants of spontaneous hepatitis b surface antigen seroclearance: a community-based follow-up study. Gastroenterology. 2010;139(2):474–82. doi:10.1053/j.gastro.2010.04.048.
   PubMed Web of Science ®Google Scholar
• GONG X, WANG F, LI H. Investigation on transformation of 197 HBsAg carriers. Chin J Public Health. 2006;2006:58.
   Google Scholar
• Jia Y, Li L, Cui F, Zhang D, Zhang G, Wang F, Gong X, Zheng H, Wu Z, Miao N. Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China. Hum Vaccin Immunother. 2014;10(10):2983–91. doi:10.4161/hv.29944.
   PubMed Web of Science ®Google Scholar
• Nguyen VTT, Law MG, Dore GJ. Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burden. J Viral Hepat. 2009;16(7):453–63. doi:10.1111/j.1365-2893.2009.01117.x.
   PubMed Web of Science ®Google Scholar
• Beijing 1% population sample survey in 2015. 2017. Office for Beijing 1% population sample survey, Beijing Municipal Bureau of Statistics. China Statistics Press.
   Google Scholar
• Dan W, Qian B, Shi-Wen S, Jiang WU, Min L, Yi-Wei G, et al. Survey on the overall cost of hepatitis b vaccination in beijing in 1992-2013. Chinese Preventive Medicine; 2019.
   Google Scholar
• Hutton DW, So SK, Brandeau ML. Cost‐effectiveness of nationwide hepatitis B catch‐up vaccination among children and adolescents in China. Hepatology. 2010;51(2):405–14. doi:10.1002/hep.23310.
   PubMed Web of Science ®Google Scholar
• Jian Z, Economics SO, University NN. A study of the impacts of rmb exchange rate volatility adjustment on rmb exchange rate volatility mechanism. Review of Economy and Management; 2018.
   Google Scholar
• Hepatitis B vaccines: WHO position paper-recommendations. Vaccine. 2010;28(3):589–90. PMID: 19896455. doi:10.1111/j.1524-4733.2010.00733.x.
   PubMedGoogle Scholar
• Xuan Z, Yan J, Xiao-Wei M, Li-Ying Z, Qi-Xin X, Wei C. Recurrent health expenses in primary healthcare institutions in beijing. Chin Gen Pract. 2018;21:2209–15.
   Google Scholar
• Xu L, Wang Y, Collins CD, Tang S. Urban health insurance reform and coverage in China using data from national health services surveys in 1998 and 2003. BMC Health Serv Res. 2007;7(1):37. PMID:17335584. doi:10.1186/1472-6963-7-37.
   PubMedGoogle Scholar
• Statistical bulletin of Beijing’s national economic and social development in 2016. (EB/OL). [2017 Feb 25]. http://www.beijing.gov.cn/gongkai/shuju/tjgb/201706/t20170608_1838189.html
   Google Scholar
• Lee D, Park S M. Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies to Prevent Perinatal Transmission in North Korea: Selective Vaccination vs. Universal Vaccination[J]. Plos One, 2016, 11(11):e0165879.
   Google Scholar
• Chen C. Zhuang Hui: epidemiological status of chronic hepatitis B in China. Liver Doctor. 2018;000:8–9.
   Google Scholar
• Qiao FY, Wu M. A study on direct economic burden of diseases related to hepatitis B viral infection in Xicheng district of Beijing. Capital J Public Health. 2011;5:247–50.
   Google Scholar
• Yan LI, Huai W, Wei Z, Yan-Hong W, Zhong-Ping D, Hui LI, et al. Investigation on the cost of patients with different outcomes related to hepatitis b virus infection in Beijing. basic & clinical medicine; 2014.
   Google Scholar
• Wang Z, Zhang H, Yang H, Li X, Wen S, Guo Y, Sun J, Hou J. Quantitative analysis of HBV DNA level and HBeAg positive mothers and their babies: hBsAg passage through the placenta and rate of decay in babies. J Med Virol. 2003;71(3):360–66. doi:10.1002/jmv.10493.
   PubMed Web of Science ®Google Scholar
• Guo Y, Gao P, Wang H, Wu J, Bai Q, Huang L, Shi X. Risk factors of hepatitis B virus infection between vaccinated and unvaccinated groups among spouses in 2006 and 2014: a cross-sectional study in Beijing. Hum Vaccin Immunother. 2019;1–10.
   PubMed Web of Science ®Google Scholar